BerandaAVHHL • OTCMKTS
add
AVITA Medical Inc
Tutup sebelumnya
$2,67
Rentang hari
$1,86 - $1,86
Rentang tahun
$1,41 - $3,28
Kapitalisasi pasar
233,07Â jt USD
Volume Rata-Rata
55,00
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 19,55Â jt | 43,25% |
Biaya operasional | 30,16Â jt | 44,75% |
Laba bersih | -16,20Â jt | -86,01% |
Margin laba bersih | -82,91 | -29,85% |
Penghasilan per saham | -0,93 | -75,60% |
EBITDA | -13,50Â jt | -47,63% |
Tarif pajak efektif | 0,17% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 44,40Â jt | -26,14% |
Total aset | 81,05Â jt | 0,05% |
Total liabilitas | 68,82Â jt | 281,59% |
Total ekuitas | 12,23 jt | — |
Saham yang beredar | 26,22 jt | — |
Harga terhadap nilai buku | 5,67 | — |
Tingkat pengembalian aset | -40,88% | — |
Tingkat pengembalian modal | -54,41% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -16,20Â jt | -86,01% |
Kas dari operasi | -7,21Â jt | 19,61% |
Kas dari investasi | 7,39Â jt | -66,02% |
Kas dari pembiayaan | 1,01Â jt | 67,83% |
Perubahan kas bersih | 1,19Â jt | -91,12% |
Arus kas bebas | -5,35Â jt | 35,08% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
207
